Spire Healthcare Group (LON:SPI) Trading 14.1% Higher - Here's Why

Key Points

• Spire Healthcare Group's share price surged by 14.1% during trading, reaching a last trade price of GBX 247 ($3.33).
• Analyst ratings are generally positive, with Berenberg Bank reaffirming a "buy" rating and setting a target price of GBX 280, while the consensus rating for the stock is currently "Buy" with an average target price of GBX 294.33.
• The company reported earnings per share of GBX 4.10 for the last quarter and has a market capitalization of approximately £993.86 million.

Shares of Spire Healthcare Group plc (LON:SPI - Get Free Report) were up 14.1% during trading on Saturday . The stock traded as high as GBX 256.50 ($3.47) and last traded at GBX 247 ($3.34). Approximately 9,747,062 shares traded hands during trading, an increase of 563% from the average daily volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.93).

Analysts Set New Price Targets

SPI has been the topic of a number of research analyst reports. Berenberg Bank reissued a "buy" rating and issued a GBX 280 target price on shares of Spire Healthcare Group in a research report on Thursday, July 31st. JPMorgan Chase & Co. cut their target price on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a research report on Tuesday, August 5th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Spire Healthcare Group has a consensus rating of "Buy" and a consensus price target of GBX 294.33.

Spire Healthcare Group Trading Down 4.7%

The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74. The business's 50 day moving average is GBX 218.75 and its 200 day moving average is GBX 203.55. The stock has a market cap of £947.58 million, a price-to-earnings ratio of 5,119.57, a P/E/G ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. As a group, equities analysts expect that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.